Although their therapeutic targets are different, levodopa, dopamine agonists, inhibitors of amine oxidase B, and acetylcholinesterase inhibitors have all been reported to be effective in improving PD gait [13, 33–36]. The gene discussed is ACHE; the disease is Parkinson disease.